WUH: Prose: A prospective Observational study of adult patients receiving Dupixent for Atopic Dermatitis
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Atopic Dermatitis
-
Age: Between 18 - 100 Years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Initiating treatment with DUPIXENT for Atopic dermatitis (AD)
- Willing and able to comply with study-related activities
- Able to understand and complete study-related questionnaires
- Provide signed informed consent
You may not be eligible for this study if the following are true:
-
- Have a contraindication to the drug
- Any condition that, in the opinion of the investigator, may interfere with patient’s ability to participate in the study
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.